SLC5A2 and Insulin resistance: Previous studies have shown that SGLT2 inhibitors improve insulin resistance by preserving mitochondrial fatty acid oxidation rates in the heart, muscle, and fat tissue under conditions of chronic lipid overload (Joannides et al., 2017; Makrecka-Kuka et al., 2020).